Matthias J. Schnell
Affiliations: | Immunology and Microbial Pathogenesis | Thomas Jefferson University, Philadelphia, PA, United States |
Area:
Immunology, Virology Biology, Microbiology BiologyGoogle:
"Matthias Schnell"Children
Sign in to add trainee| Philip M. McKenna | grad student | 2006 | Thomas Jefferson |
| Gene S. Tan | grad student | 2007 | Thomas Jefferson |
| Elizabeth J. Faul | grad student | 2010 | Thomas Jefferson |
| Emily A. Gomme | grad student | 2012 | Thomas Jefferson |
| Tessa M. Lawrence | grad student | 2013 | Thomas Jefferson |
| Celestine N. Wanjalla | grad student | 2013 | Thomas Jefferson |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rios S, Bhattachan B, Vavilikolanu K, et al. (2024) The Development of a Rabies Virus-Vectored Vaccine against , Targeting BBI39. Vaccines. 12 |
| Scher G, Bente DA, Mears MC, et al. (2023) GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus. Npj Vaccines. 8: 73 |
| Yankowski C, Kurup D, Wirblich C, et al. (2023) Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge. Npj Vaccines. 8: 10 |
| Yankowski C, Wirblich C, Kurup D, et al. (2022) Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity. Npj Vaccines. 7: 110 |
| Kurup D, Wirblich C, Zabihi Diba L, et al. (2022) A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model. Viruses. 14 |
| Kurup D, Myers J, Schnell MJ. (2022) Current vaccine strategies against SARS-CoV-2: Promises and challenges. The Journal of Allergy and Clinical Immunology |
| Kurup D, Wirblich C, Lambert R, et al. (2022) Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract. Npj Vaccines. 7: 43 |
| Malherbe DC, Kurup D, Wirblich C, et al. (2021) A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19. Npj Vaccines. 6: 91 |
| Kurup D, Schnell MJ. (2021) SARS-CoV-2 vaccines - the biggest medical research project of the 21st century. Current Opinion in Virology. 49: 52-57 |
| Kurup D, Malherbe DC, Wirblich C, et al. (2021) Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model. Plos Pathogens. 17: e1009383 |